STOCK TITAN

Vuzix 10-Q Filings

VUZI NASDAQ

Every 10-Q that Vuzix (VUZI) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A 10-Q covers the quarterly report filed between annual reports, so if you follow VUZI and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full VUZI filings page.

Rhea-AI Summary

Vuzix Corporation reported Q2 2026 sales of $1,113,498, down 14% from Q2 2025, and a six‑month 2026 revenue total of $2,504,813, down 13%. Product sales fell 19% year to date, partly offset by a 14% increase in engineering services revenue. Gross margin remained negative, with a six‑month gross loss of $1,023,331.

Operating expenses were high relative to revenue, though trending lower in some areas: research and development rose 18% year to date to $6,126,229, while general and administrative expenses fell 28% to $4,816,272. Net loss for the first half of 2026 was $14,700,019, an improvement from $16,303,881 a year earlier. Cash and cash equivalents were $17,297,697 with working capital of $18,014,817, supported by $9,914,210 in net equity raised under an at‑the‑market program. Management cites recurring losses, cash burn, and an accumulated deficit of $414,633,429, but concludes that substantial doubt about continuing as a going concern has been alleviated based on current liquidity and access to capital.

Rhea-AI Summary

Vuzix Corporation reported another quarterly loss while strengthening its cash position through equity sales. For the three months ended March 31, 2026, revenue was $1.39 million, down 12% year over year, as product sales fell 21% and engineering services grew 36%.

The company posted a net loss of $7.07 million, improving from a loss of $8.64 million a year earlier, with lower general and administrative expenses and depreciation partly offset by higher research and development spending. Gross margin remained negative, with a gross loss of $0.38 million.

Vuzix ended the quarter with $20.17 million of cash and cash equivalents and positive working capital of $20.78 million, supported by $5.78 million of net proceeds from its at-the-market equity program. Management acknowledges historical losses and cash burn but believes, based on current cash, cost actions, and continued access to capital markets, that substantial doubt about continuing as a going concern has been alleviated.

Rhea-AI Summary

Vuzix Corporation reported third‑quarter 2025 results with total sales of $1.16 million, down 16% year over year, reflecting lower Smart Glasses unit sales and reduced engineering services. Cost of sales exceeded revenue, producing a gross loss of $411,307.

Operating expenses declined versus last year, narrowing the operating loss to $7.49 million. Net loss was $7.35 million (basic and diluted loss per share $0.09), compared with a $9.22 million loss a year ago. Cash and cash equivalents were $22.61 million at September 30, 2025.

The company raised equity to support liquidity: year‑to‑date ATM sales generated $9.64 million net (including $5.55 million in Q3), and Vuzix issued $10 million of Series B Preferred Stock to Quanta in two 2025 closings tied to milestones. Management disclosed substantial doubt indicators but stated that planned capital raises and operational actions have alleviated doubt about continuing as a going concern.